Maximal Tolerated Dose (MTD) Following a Single Injection 16 weeks [clinicaltrials_resource:98f3a6bb93aff5c80935257fdd00421f]
MTD was defined as one dose level below the lower of the dose level in which a severe (sight-threatening) drug-related Adverse Event occurred or the dose level at which more than 2 patients experienced a moderate ocular (eye) drug-related toxicity.
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Maximal Tolerated Dose (MTD) Following a Single Injection 16 weeks [clinicaltrials_resource:98f3a6bb93aff5c80935257fdd00421f]
MTD was defined as one dose level below the lower of the dose level in which a severe (sight-threatening) drug-related Adverse Event occurred or the dose level at which more than 2 patients experienced a moderate ocular (eye) drug-related toxicity.
Bio2RDF identifier
98f3a6bb93aff5c80935257fdd00421f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:98f3a6bb93aff5c80935257fdd00421f
measure [clinicaltrials_vocabulary:measure]
Maximal Tolerated Dose (MTD) Following a Single Injection
time frame [clinicaltrials_vocabulary:time-frame]
description
MTD was defined as one dose le ...... r (eye) drug-related toxicity.
identifier
clinicaltrials_resource:98f3a6bb93aff5c80935257fdd00421f
title
Maximal Tolerated Dose (MTD) Following a Single Injection 16 weeks
@en
type
label
Maximal Tolerated Dose (MTD) F ...... 3a6bb93aff5c80935257fdd00421f]
@en